# Addgene

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/addgene/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 74 |
| Citations | 56,342 |
| City | Cambridge |
| Country | US |
| Description | Addgene is a research organisation in Cambridge, US. OpenAlex records 483 works and 56,342 citations for it. 356 researchers list it as their most recent affiliation. |
| Homepage | https://www.addgene.org/ |
| OpenAlex ID | https://openalex.org/I4210108476 |
| Region | Massachusetts |
| Researchers | 356 |
| ROR ID | https://ror.org/01nn1pw54 |
| Type | nonprofit |
| Works | 483 |

## University papers

Showing 12 of 13.

- [A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells](https://scholariq.org/papers/a-key-role-for-autophagy-and-the-autophagy-gene-atg16l1-in-mouse-and-human/)
- [A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity](https://scholariq.org/papers/a-human-natural-killer-cell-subset-provides-an-innate-source-of-il-22-for/)
- [Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer](https://scholariq.org/papers/molecular-mechanisms-of-resistance-to-first-and-second-generation-alk-inhibitors/)
- [COVID-19-neutralizing antibodies predict disease severity and survival](https://scholariq.org/papers/covid-19-neutralizing-antibodies-predict-disease-severity-and-survival/)
- [Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma](https://scholariq.org/papers/polyclonal-secondary-i-fgfr2-i-mutations-drive-acquired-resistance-to-fgfr/)
- [Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation](https://scholariq.org/papers/clinical-acquired-resistance-to-krasg12c-inhibition-through-a-novel-kras-switch/)
- [Origins of lymphatic and distant metastases in human colorectal cancer](https://scholariq.org/papers/origins-of-lymphatic-and-distant-metastases-in-human-colorectal-cancer/)
- [An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background](https://scholariq.org/papers/an-ultraviolet-radiation-independent-pathway-to-melanoma-carcinogenesis-in-the/)
- [Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i> -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion](https://scholariq.org/papers/landscape-of-acquired-resistance-to-osimertinib-in-i-egfr-i-mutant-nsclc-and/)
- [<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib](https://scholariq.org/papers/i-met-i-amplification-identifies-a-small-and-aggressive-subgroup-of/)
- [Clinicopathologic Features of Non–Small-Cell Lung Cancer Harboring an <i>NTRK</i> Gene Fusion](https://scholariq.org/papers/clinicopathologic-features-of-non-small-cell-lung-cancer-harboring-an-i-ntrk-i/)
- [The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer](https://scholariq.org/papers/the-clinical-landscape-of-cell-free-dna-alterations-in-1671-patients-with/)

## University researchers

- [Jochen K. Lennerz](https://scholariq.org/researchers/jochen-k-lennerz/)

## University top topics

Showing 8 of 25.

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.